Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.

Results of the updated systematic review informing the 2024 EULAR recommendations showed that many ARDs are safe to use during pregnancy, lactation, and reproduction.

Menopausal Hormone Therapy (MHT) is first-line treatment for the relief of menopausal symptoms. Although the majority of ...